Nuvation Bio Inc.
NUVB
$8.11
$0.648.57%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,704.68% | 236.79% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,704.68% | 236.79% | -- | -- | -- |
| Cost of Revenue | 121.06% | 91.24% | -- | -- | -- |
| Gross Profit | 1,339.97% | 2,464.77% | -- | -- | -- |
| SG&A Expenses | 90.78% | 138.20% | 381.08% | 376.97% | 151.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.45% | 46.36% | 207.38% | 186.37% | 85.38% |
| Operating Income | -17.32% | -40.33% | -192.11% | -158.95% | -82.62% |
| Income Before Tax | -35.38% | 87.24% | -259.90% | -258.63% | -109.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.38% | 87.24% | -259.90% | -258.63% | -109.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.38% | 87.24% | -259.90% | -258.63% | -109.73% |
| EBIT | -17.32% | -40.33% | -192.11% | -158.95% | -82.62% |
| EBITDA | -16.61% | -40.30% | -191.42% | -158.58% | -82.39% |
| EPS Basic | -8.17% | 90.83% | -132.89% | -132.86% | -67.89% |
| Normalized Basic EPS | -8.18% | -13.30% | -132.94% | -132.15% | -67.74% |
| EPS Diluted | -8.17% | 90.83% | -128.57% | -132.86% | -67.89% |
| Normalized Diluted EPS | -8.18% | -13.30% | -132.94% | -132.15% | -67.74% |
| Average Basic Shares Outstanding | 25.16% | 39.23% | 54.58% | 53.86% | 24.95% |
| Average Diluted Shares Outstanding | 25.16% | 39.23% | 54.58% | 53.86% | 24.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |